Acorda Therapeutics
ACOR
#10361
Rank
A$1.28 M
Marketcap
$1.03
Share price
0.00%
Change (1 day)
-95.52%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -A$0.41 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2023 the company made an earning of -A$0.42 Billion a decrease over its 2022 earnings that were of -A$8.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.41 Billion-3.13%
2023 -A$0.42 Billion4848.63%
2022 -A$8.36 Million-93.25%
2021 -A$0.13 Billion2.52%
2020 -A$0.13 Billion-69.45%
2019 -A$0.4 Billion-700.62%
2018 A$65.77 M-118.02%
2017 -A$0.37 Billion805.99%
2016 -A$40.3 Million-173.88%
2015 A$54.53 M-6.58%
2014 A$58.37 M20.19%
2013 A$48.57 M18.7%
2012 A$40.91 M-26.54%
2011 A$55.7 M
2009 -A$0.13 Billion10.65%
2008 -A$0.12 Billion86.17%
2007 -A$61.75 Million68.1%
2006 -A$36.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$30.08 M-107.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.61 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
A$0.20 B-147.61%๐Ÿ‡บ๐Ÿ‡ธ USA